Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Because gene is an important clinical risk factor resulting in AD, genomic studies, such as genome-wide association studies (GWAS), have widely been applied into AD studies. However, main shortcomings of GWAS method were that hereditary deletions were evident in the GWAS s...
The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors play a key role in treating Alzheimer's disease. This study proposes an approach that integrates a modified binary particle swarm optimization (PSO) with a machine learning algorithm for building QSAR models to predict the activity of inhibitors for AChE and BuChE enzymes. More precisely, it uses a transfer function to co...
Hallucinations in Parkinson's disease (PD) are disturbing and frequent non-motor symptoms and constitute a major risk factor for psychosis and dementi...
OBJECTIVE: A predictive model of Alzheimer's disease (AD) was established based on brain surface meshes and geometric deep learning, and its performan...
Omics technologies offer great promises for improving our understanding of diseases. The integration and interpretation of such data pose major challe...
The analysis of neural circuits can provide crucial insights into the mechanisms of neurodegeneration and dementias, and offer potential quantitative ...
Exon splicing triggered by unpredicted genetic mutation can cause translational variations in neurodegenerative disorders. In this study, we discover ...
Functional connectivity (FC) matrices measure the regional interactions in the brain and have been widely used in neurological brain disease classific...
Diffusion MRI is the modality of choice to study alterations of white matter. In past years, various works have used diffusion MRI for automatic class...
AIM AND OBJECTIVE: Fast and accurate diagnosis of Alzheimer's disease is very important for the care and further treatment of patients. Along with the...
BACKGROUND: In recent years, many convolutional neural networks (CNN) have been proposed for the classification of Alzheimer's disease. Due to memory ...
BACKGROUND: Using non-pharmacological interventions is a current approach in dementia care to manage responsive behaviors, to maintain functional capa...
BACKGROUND: Sociodemographic data indicate the progressive increase in life expectancy and the prevalence of Alzheimer's disease (AD). AD is raised as...
BACKGROUND: Quantitatively predicting the progression of Alzheimer's disease (AD) in an individual on a continuous scale, such as the Alzheimer's Dise...
BACKGROUND: There is a need for more reliable diagnostic tools for the early detection of Alzheimer's disease (AD). This can be a challenge due to a n...
BACKGROUND: Amyloid-β (Aβ) evaluation in amnestic mild cognitive impairment (aMCI) patients is important for predicting conversion to Alzheimer's dise...
BACKGROUND: Mild cognitive impairment (MCI) is considered a prodromal stage of Alzheimer's disease. Early diagnosis of MCI can allow for treatment to ...
BACKGROUND: Advanced machine learning methods can aid in the identification of dementia risk using neuroimaging-derived features including FDG-PET. Ho...
We applied graph theory analysis on resting-state functional magnetic resonance imaging data to evaluate sex differences of brain functional topograph...
BACKGROUND: Many neurocognitive and neuropsychological tests are used to classify early mild cognitive impairment (EMCI), late mild cognitive impairme...